Alleviate the symptoms of Treatment Resistant Despression within 5 days or less with Accelerated TMS.
Effective deep TMS treatments are administered using the Brainsway® system, thereby mitigating the need for neuronavigation.
We specialize in accelerated TMS treatments that can provide relief for the most treatment resistant patients in 5 days or less.
We also provide conventional TMS treatments that are covered by select insurance plans.
Alleviate the symptoms of Major Depressive Disorder and acute suicidal ideation and/or behaviors within 24 hours or less with Spravato®.
Esketamine, also known by the brand name Spravato®, is a promising new antidepressant treatment that has the potential to work very quickly.
Esketamine is chemically related to ketamine and is self-administered as a nasal spray.
Unlike previous antidepressants and treatments, many patients feel better after the first or second treatment.
Esketamine works in 50–70% of patients with treatment-resistant depression.
Our Approach
Our Thinking